Utah / State / 2026 General Session

2026 Utah Laws ch 196 Directed a clinical study of psychedelic-assisted therapy for veterans with treatment-resistant PTSD

Watching a later dateEnactedProgram created

Signed 2026-03-19 · Takes effect 2027-01-01

Enacted Utah Code section 26B-7-126, directing the Huntsman Mental Health Institute within the University of Utah to conduct a clinical study of the safety and feasibility of psychedelic-assisted therapy, using MDMA, 5-methoxy-N,N-dimethyltryptamine or psilocybin, for the treatment of treatment-resistant PTSD in eligible veterans. An eligible veteran is one with a clinical PTSD diagnosis and a documented inadequate response to one or more evidence-based treatments; the section does not require the PTSD to be service-connected. The study must run under an FDA investigational new drug application, a Drug Enforcement Administration Schedule I research registration and Institutional Review Board approval, with a protocol, drug administration plan, safety monitoring and risk management plan including predefined rules for pausing or stopping the study, and a psychotherapy fidelity plan. Tracked and watching because the duty to begin is conditional: subsection 4 requires the institute to start no later than January 1, 2027 only if legislative appropriations plus gifts, grants and donations reach an amount the institute itself determines is sufficient, and subsection 5 provides that if they do not, the institute begins whenever they do. Unused donations must be returned to donors on or before July 1, 2032. This creates no entitlement to participate and is not a treatment programme, and it will be described as one.